Malisorn, N. (2015). New promising agents, boceprevir and telapevir, for new standard care for the treatment of chronic HCV infection. Journal of Basic and Applied Pharmacology, 35(1), 41–54. retrieved from https://li01.tci-thaijo.org/index.php/JBAP/article/view/32172